If the study shows that the predicted risk application is not only accurate in terms of the actual pregnancy outcome but is acceptable to participants, this may help to allocate the already limited EPAU resources more appropriately. For example, "low risk" women might not require a follow-up scan whereas "high risk" women would continue to be offered closer follow-up. Following the study, we anticipate that the use of the "App" could be extendable to other clinical sites to aid the management and expectations of women diagnosed with IPUVI. The NICE Evidence Update specifically refers to this prediction model and it is anticipated that this will be a nationally recommended tool if validated in this study to be helpful.